Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
Tunesi S, Dû DL, Gualano G, Millet JP, Skrahin A, Bothamley G, Casas X, Goletti D, Lange C, Musso M, Palmieri F, Pourcher V, Rioux C, Skrahina A, Veziris N, Viatushka D, Jachym-Fréchet M, Guglielmetti L; TBnet, The ESGMYC, and The French MDR-TB Group.
Tunesi S, et al. Among authors: guglielmetti l.
J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.004. Epub 2022 Mar 7.
J Infect. 2022.
PMID: 35271917
No abstract available.